We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
[Histamine and the convulsive threshold or effectiveness of antiepileptic drugs].
Przegla̧d Lekarski 2008
BACKGROUND: A problem of influence of antihistaminic drugs upon the convulsive threshold and effectiveness of antiepileptic drugs appears significant because of the increasing prevalence of allergic diseases in 21st century which results in significant intake of anti-allergic drugs. Existing experimental data provide data on the possible interactions between antiepileptic and antihistaminic drugs.
THE AIM OF STUDY: To characterize the importance of histamine and anti-histaminic drugs in seizure susceptibility and evaluate interactions between antiepileptic and antihistaminic drugs.
RESULTS: Histamine, apartfrom its various activities, takes also part in the inhibition of seizures via H1 histamine receptors. H1 receptor antagonists (antazoline, ketotifen, astemizole), especially when administered chronically, impaired the anticonvulsant activity of some antiepileptic drugs (phenobarbital, phenytoin, valproate) against maximal electroshock-induced convulsions in mice. Valproate was resistant to this hazardous effect of antihistaminic drugs.
CONCLUSION: It may be postulated that a possible use of antihistaminic drugs in epileptic drugs needs to be carefully considered in terms of risk/benefit ratio.
THE AIM OF STUDY: To characterize the importance of histamine and anti-histaminic drugs in seizure susceptibility and evaluate interactions between antiepileptic and antihistaminic drugs.
RESULTS: Histamine, apartfrom its various activities, takes also part in the inhibition of seizures via H1 histamine receptors. H1 receptor antagonists (antazoline, ketotifen, astemizole), especially when administered chronically, impaired the anticonvulsant activity of some antiepileptic drugs (phenobarbital, phenytoin, valproate) against maximal electroshock-induced convulsions in mice. Valproate was resistant to this hazardous effect of antihistaminic drugs.
CONCLUSION: It may be postulated that a possible use of antihistaminic drugs in epileptic drugs needs to be carefully considered in terms of risk/benefit ratio.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app